Evidence map›Paper›PMID 24152939›Full record

ReviewLancet (London, England)2013

The end of AIDS: HIV infection as a chronic disease.

Steven G Deeks, Sharon R Lewin, Diane V Havlir

3 registry-linked trialsAbstract readReview
In one paragraph

Review in Lancet (London, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 1,054 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,054citing papers in PubMed, 6 pooled it
114.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02975258 completednot on this mapstarted 2015, after this paper: background citation

Adiposity and Airway Inflammation in HIV-Associated Airway Disease

TypeobservationalSponsorUniversity of PittsburghRan2015 to 2017Enrolled102ConditionsAsthma, HIV, AdiposityArmsBlood draw, Questionnaires, Spirometry, Methacholine challenge test, Quantitative CT scans
NCT04002323 completednot on this mapstarted 2019, after this paper: background citation

Real Life Study of Dolutegravir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients

Typeobservational_patient_registrySponsorUniversity Hospital Virgen de las NievesRan2019 to 2022Enrolled88ConditionsHIV-1-infectionArmsDolutegravir 50mg Tab, Lamivudine 300 mg
NCT04160455 recruitingnot on this mapstarted 2019, after this paper: background citation

Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.

TypeobservationalSponsorCentre Hospitalier Régional d'OrléansRan2019 to 2039Enrolled180ConditionsAutophagy, Galectins, HIV Infections, Highly Active Antiretroviral TherapyArmsexpression of a panel
3 · Its place in the literature

Who cites it

1,054 citing papers in PubMed, 6 syntheses or guidelines pooled it, 2,030 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Measurement and evaluation of community engagement in complex, chronic medical conditions: HIV and obesity as exemplar conditions.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Phase 1 Evaluation of VH4524184, a Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Observational
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

994 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Steven G DeeksDepartment of Medicine, University of California, San Francisco, CA, USA. Electronic address: sdeeks@php.ucsf.edu.
Sharon R Lewin
Diane V Havlir
Monash University · AUUniversity of California, San Francisco · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
Viral reservoirs and sanctuaries in HAART - treated patients: role and mechanismsU19AI096109 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHACKER, TIMOTHY W · 2011 to 2015
$29.5M
Preventing the Establishment of Enfuvirtide-resistance in the Latent ReservoirK24AI069994 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEEKS, STEVEN GRANT · 2007 to 2016
$1.5M
Therapeutic Strategies for HIV DiseaseK24AI051982 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 2002 to 2012
$1.3M
The role of chemokines in the establishment of HIV latencyR56AI095073 · NIAID · MONASH UNIVERSITY · PI LEWIN, SHARON RUTH · 2012 to 2012
$271k
NIAID NIH HHS 1R56AI095073-01A1NIAID NIH HHS K24 AI051982NIAID NIH HHS K24 AI069994NIAID NIH HHS P30 AI027763NIAID NIH HHS P30AI027763NIAID NIH HHS R56 AI095073NIAID NIH HHS U19 AI096109NIAID NIH HHS U19AI096109NIAID NIH HHS UM1 AI069496PHS HHS A1027763PHS HHS A151982
6 · The paper itself

Abstract

The success of antiretroviral therapy has led some people to now ask whether the end of AIDS is possible. For patients who are motivated to take therapy and who have access to lifelong treatment, AIDS-related illnesses are no longer the primary threat, but a new set of HIV-associated complications have emerged, resulting in a novel chronic disease that for many will span several decades of life. Treatment does not fully restore immune health; as a result, several inflammation-associated or immunodeficiency complications such as cardiovascular disease and cancer are increasing in importance. Cumulative toxic effects from exposure to antiretroviral drugs for decades can cause clinically-relevant metabolic disturbances and end-organ damage. Concerns are growing that the multimorbidity associated with HIV disease could affect healthy ageing and overwhelm some health-care systems, particularly those in resource-limited regions that have yet to develop a chronic care model fully. In view of the problems inherent in the treatment and care for patients with a chronic disease that might persist for several decades, a global effort to identify a cure is now underway.

Indexed as

Acquired Immunodeficiency SyndromeAgingAnti-HIV AgentsChronic DiseaseComorbidityDelivery of Health CareGlobal HealthHIV InfectionsHumansAnti-HIV Agents

Identifiers

PMID24152939
PMCPMC4058441
OpenAlexW2125377515

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.